Key Vendors in Allergic Rhinitis Drugs Market in the AstraZeneca, GlaxoSmithKline, Meda Pharmaceuticals, Merck, Sanofi and UCB Says a 2020 Report

The analysts forecast global allergic rhinitis market to grow at a CAGR of 0.95% during the period 2016-2020.

Allergic rhinitis is caused by the interaction of airborne allergens with specific immunoglobulin E (IgE) type antibodies on the surface of mast cells. This interaction causes mast cells to release and synthesize chemicals, causing inflammation of the surrounding tissues. Typical symptoms include rhinorrhea, nasal itching, sneezing, and nasal congestion. Extranasal symptoms such as allergic conjunctivitis, itchy ears and palate, and asthma may also occur. Allergic rhinitis is treated using medications such as antihistamines, intranasal corticosteroids, or immunotherapies. Alternative forms of treatment are also employed in certain cases.

Covered in this report

The report covers the present scenario and the growth prospects of the global allergic rhinitis drugs market for the period 2016-2020. To calculate the market size, it considers revenue generated from the sales of prescription and off-label drugs used to treat allergic rhinitis.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • Europe

The report, Global Allergic Rhinitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Purchase a copy of the report at .

Key vendors

  • AstraZeneca
  • GlaxoSmithKline
  • Meda Pharmaceuticals
  • Merck
  • Sanofi
  • UCB

Other prominent vendors

  • Adamis Pharmaceuticals
  • Alcon
  • Alergo Pharma
  • ALK-Abelló
  • Allergy Therapeutics
  • Almirall
  • Ampio
  • Anergis
  • Apotex
  • Ares Life Sciences
  • Array BioPharma
  • Aspen Pharmacare
  • Atopix Therapeutics
  • Barr Laboratories
  • Belcher Pharmaceuticals
  • Circassia Pharmaceuticals
  • Dainippon Sumitomo
  • DBV Technologies
  • Dr Reddy’s Laboratories
  • Eddingpharm
  • Genentech
  • Greer Laboratories
  • Hanmi Pharmaceuticals
  • Hisamitsu Pharmaceutical
  • Intas Pharmaceuticals
  • Kyowa Hakko
  • Lupin Pharmaceuticals
  • Mitsubishi Tanabe Pharma
  • Mylan
  • Nektar Therapeutics
  • Novartis
  • Nuvo Research
  • Nycomed
  • Omega Pharma
  • Ono Pharmaceuticals
  • Pfizer
  • Revance Therapeutics
  • Roxane Laboratories (Boehringer Ingelheim)
  • Shionogi
  • Stallergenes
  • Sun Pharmaceuticals
  • Takeda Pharmaceutical
  • Teva Pharmaceuticals
  • Verona Pharma
  • VentiRx Pharmaceuticals

Market driver

  • Increased prevalence of allergic rhinitis

Market challenge

  • Patent expiries and competition from generic drugs

Market trend

  • Increased R&D

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

For more Information on the report, inquire at .

About US:  is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.